Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01500902 · ClinicalTrials.gov registry record · NA
Prediction of Cardiovascular Events in Vulnerable Patients Following Acute Coronary Syndrome
A NA study, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 101
- Enrollment target
NCT01500902: Completed NA study, sponsored by Mayo Clinic.
NCT01500902 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 101 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01500902, a NA study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 101 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if testing patients for endothelial dysfunction will help identify which patients are more likely at risk to have another heart attack in the future. Study participants will undergo mental stress testing while at the same time being connected to a device that measures endothelial function via the Endopat device. These same participants will also undergo a sleep study via the Watchpat device.
Interventions
- OTHER EndoPAT testing (non invasive device)
- OTHER WatchPAT testing (non-invasive device)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 101 participants |
| Start Date | 2011-09 |
| Est. Completion | 2015-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01500902
The ClinicalTrials.gov registry entry for NCT01500902 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 101 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which EndoPAT testing (non invasive device) is the first listed.
NCT01500902 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01500902 about?
NCT01500902 is a clinical study titled "Prediction of Cardiovascular Events in Vulnerable Patients Following Acute Coronary Syndrome". The purpose of this study is to determine if testing patients for endothelial dysfunction will help identify which patients are more likely at risk to have another heart attack in the future. Study participants will undergo mental stress testing while at the same time being connected to a device tha...
What is the current status of trial NCT01500902?
This trial is currently completed. It is a NA study. The enrollment target is 101 participants. The study started on 2011-09. Estimated completion is 2015-04.
What interventions are being tested in trial NCT01500902?
The interventions under investigation include: EndoPAT testing (non invasive device) (OTHER), WatchPAT testing (non-invasive device) (OTHER).
Who is sponsoring clinical trial NCT01500902?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.